Craig Thompson

Craig Thompson   (biologist)
Born	1953
Nationality	US
Alma mater	University of Pennsylvania Medical School, Harvard Medical School, Fred Hutchinson Cancer Research Center
Spouse	Tullia Lindsten
Interests	cancer
President of Memorial Sloan Kettering Cancer Center and board member of Big Pharma Merck who attended the 2013 Bilderberg meeting, where one of the subjects was "Major Trends in Medical Research"

Craig B. Thompson is an American cell biologist who was president of the research institution Memorial Sloan Kettering Cancer Center 2010-2022. He attended the 2013 Bilderberg meeting, where one of the subjects was "Major Trends in Medical Research", presumably either lobbying for Big Pharma (having an interests in Merck), or for some deep state agenda under a medical pretext.

Education

Thompson received his bachelor's degree from Dartmouth College and went on to get his medical degree in 1977 from the University of Pennsylvania Medical School. He received clinical training in internal medicine at Harvard Medical School and in medical oncology at the Fred Hutchinson Cancer Research Center at the University of Washington.

Career

After completing his training, Thompson became a physician at the National Naval Medical Center in Bethesda, Maryland, and an assistant professor of medicine at the Uniformed Services University of the Health Sciences. In 1987, he joined the faculty of the University of Michigan as an assistant professor of medicine and an assistant investigator in the Howard Hughes Medical Institute. From 1993 until he joined the University of Pennsylvania, he was affiliated with the University of Chicago, where he was professor of medicine, a Howard Hughes investigator, and director of the Gwen Knapp Center for Lupus and Immunology Research.

Thompson joined the University of Pennsylvania in 1999 as a professor of medicine, the scientific director of The Leonard and Madlyn Abramson Family Cancer Research Institute, and the first chairman of the Department of Cancer Biology. In 2006 he was named director of the Abramson Cancer Center of the University of Pennsylvania and associate vice president for cancer services of the University of Pennsylvania Health System.

Thompson became president and chief executive officer of Memorial Sloan Kettering Cancer Center in November 2010.

Resigning from Merck

In 2018, Thompson, the chief executive of Memorial Sloan Kettering Cancer Center, said that he would resign his seats on the boards of drugmaker Merck and another public company, "the latest fallout from a widening institutional reckoning over relationships between cancer center leaders and for-profit health care companies". Thompson has served on the board of Merck, the maker of the blockbuster cancer drug Keytruda, since 2008.

Covid

In December 2020, the Memorial Sloan Kettering (MSK) rolled up their sleeves to receive the COVID-19 vaccine. "We are encouraged by the demonstrated safety and efficacy of the Pfizer vaccine, as well as the Moderna vaccine, which is expected to be approved by the FDA soon," said Craig B. Thompson, MD, president and CEO of MSK. "The Pfizer vaccine was approved after successful large-scale trials with more than 43,000 volunteer participants, rigorous peer review by independent scientists, and adherence to FDA regulatory standards."

He interviewed Rochelle Walensky at the Economic Club of New York in April 2022.

 

Event Participated in

Event	Start	End	Location(s)	Description
Bilderberg/2013	6 June 2013	9 June 2013	Watford UK	The 2013 Bilderberg group meeting.

Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.